Clinical Trial Update: T-Cell Therapy for Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a T-cell therapy in advanced breast cancer, including metastatic HER2-negative disease. The study status is active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• T-cell therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Metastatic HER2-negative Breast | Phase 1 | Status: ACTIVE_NOT_RECRUITING